Study of portal vein clots in cirrhosis and their treatment
Part of Digestive system clinical trials.
This study tracks people with liver cirrhosis to see how often portal vein thrombosis (a blood clot in the main vein to the liver) occurs and how it can be treated with blood thinners. It aims to improve care for those at risk of these clots.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older.
- You have been diagnosed with liver cirrhosis (scarring of the liver) from any cause.
- You have had an ultrasound, CT scan, or MRI of your abdomen within the last 3 months to look for a blood clot in the portal vein (the large vein to the liver).
- You do not currently have any type of cancer (including liver cancer).
- You have not had a TIPS procedure, spleen removal, or liver transplant in the past.
- You are willing and able to follow up with the study team for 2 years.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at how blood clots in the portal vein (the main vein to your liver) affect recovery and outcomes after a liver transplant. If you've had a liver transplant, your data may help doctors understand this better.
This study looks at factors that help open up blood clots in the main vein to the liver (portal vein) in people with cirrhosis and varices. It might help guide treatment to improve blood flow.
This trial tests whether placing a small tube (TIPS) at the time of variceal bleeding can prevent future bleeding in people with cirrhosis and a large clot in the liver's main vein. It aims to see if early TIPS treatment is better than standard care.
This trial compares two blood-thinning medications, dabigatran (a pill) and enoxaparin (a shot), to see which works better and is safer for people with cirrhosis who have a blood clot in the portal vein (the main vein to the liver). It may help prevent the clot from getting worse or causing complications.
This Phase 4 study looks at how clotting measurements relate to bleeding risk in people with liver cirrhosis who need a planned liver procedure. The study may help doctors understand what coagulation results mean when doing these procedures safely.
This study looks at blood clotting in patients with cirrhosis who are getting a TIPS—a tube placed in the liver to help blood flow. The study aims to understand how the procedure affects bleeding and clotting, which could help make it safer for people with liver disease.
Hear when a new Portal Vein Thrombosis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.